Airtech Contracts License Rights to Akacid Biocide Breakthrough.

Business Editors & Health/Medical Writers

DALLAS--(BUSINESS WIRE)--Dec. 19, 2001

Airtech International Group, Inc. (OTCBB: AIRG) announced that it has signed a contract with Equity Concepts, Inc. of St. Louis, MO, for the marketing rights to Akacid(R) biocide. Akacid(R) is a highly effective non-toxic polymeric antiseptic preparation that has a broad cross-section of capabilities as an antiseptic, antiviral, fungicidal, insecticidal, and algae suppressor.

Among other applications, Akacid(R) can be used as: an antiseptic for the suppression of intra-hospital diseases; an air filtration and disinfectant for large scale HVAC systems; emergency decontamination of buildings, equipment and personnel from a biological threat; and a fungicide for the conservation of a large variety of materials.

According to Airtech's CEO, John Harris, "This is a major contract for Airtech that I feel will produce extraordinary results for the Company. Akacid(R) is a market changing product that will be incorporated into our existing and future products, and has the potential to greatly expand both the products and services of the Company. It is the consummate product. Equity Concept's testing has shown its safety, and exceptional killing power in destroying airborne and surface bacteria, viruses, fungi and many additional biologicals. Competitive biocides that Airtech has reviewed often include toxic levels of chlorine, ammonia and isopropyl alcohol that are as dangerous to humans and other animals as they are helpful. Approximately $5 million has been spent to date by the developers of Akacid(R) in researching its effectiveness as a biocide in FDA licensed laboratories. One small example of Akacid's use is that it will substantially reduce airborne bacteria, fungi, viruses and mold spores captured by filtration for up to six months when incorporated in an air filter used in the heating and cooling system. Akacid(R), because it nebulizes very well, can be fogged into contaminated buildings. It can be sprayed on virtually any surface or incorporated into a broad cross-section of products to inhibit mold, bacteria and fungi growth."

Harris went on to comment, "Among other uses, we intend to make Akacid(R) a key part of Airtech's three-phase photocatalytic oxidation technology, and other air cleaning products. Akacid(R) will allow Airtech to profitably participate in a larger number of vertical markets that have not been available in the past. Owners and operators of hospitals, schools, office buildings and a variety of other buildings are concerned with the presence of airborne and surface biologicals in the form of bacteria, viruses, fungi and molds. Akacid(R) is proven effective as a fast acting non-toxic biocide that is highly effective against 334 species of bacterium, virus, fungus and spores. It has been thoroughly tested, used in a variety of applications in Europe over a period of years, with important and recent formula improvements. We view Akacid(R) as a very important addition to our arsenal of homeland protection products. Airtech is excited to test the product ourselves and gauge the improvements in indoor air environments."

Equity Concept's President, Mr. Mark Diemer said, "Airtech is positioned to optimize Akacid's potential. We believe that the many potential uses of the product holds great promise for Airtech, and we are confident that we have placed our trust with the right management team and Company."

About Airtech:

Airtech founded in 1994, first achieved market recognition with its air cleaning technology by providing a solution of advanced technology and engineering to allow smokers and non-smokers to coexist in restaurants/bars. Its corporate customers include: Southwest Airlines, AlphaGraphics, El Chico's, Bennigan's, TGI Friday's, Del Frisco's Double Eagle Steakhouses, Sullivan's, and many other companies. Airtech International Group Inc. is a publicly traded company under the symbol (OTCBB:AIRG). Airsopure, Inc. is a wholly owned subsidiary of Airtech.

Forward looking Statements in this document that are not historical fact are "forward-looking statements" as that term is defined in the Private Securities Litigation Reform of 1993. Forward-looking statements are not guarantees of future performance. Our forward-looking statements are based on trends that we anticipate in our industry and our good faith estimate of the effect on these trends of such factors as industry capacity, product demand, and product pricing. These statements are also subject to risks and uncertainties beyond our reasonable control that could cause our actual business and results of operations to differ materially from those reflected in our forward-looking statements. These risks are described in the Company's Form 10-K filed September 7, 2001.